An unfortunate adverse effect of more intensive diabetic therapy is that it increases the risk for hypoglycemia
The main GLP-1 drugs that help with weight management, in addition to Type 2 diabetes, are Wegovy and Zepbound, manufactured by Novo Nordisk and Eli Lilly, respectively
doi:10.1371/journal.pone.0042357 Camacho-Pereira J, Tarrag MG, Chini CCS, et al
The peptide signaling triggered by semaglutide affects multiple satiety centers simultaneously, creating a sustained reduction in food cravings and caloric intake that supports consistent weight loss
Why Counterfeit GLP-1 Medications Are a Serious Risk Counterfeit GLP-1 medications may look convincing, but they are not held to medical safety standards
Total antioxidant capacity as a marker of severity of COVID-19 infection: Possible prognostic and therapeutic clinical application